Toggle navigation
Data Resources
Computing Analysis
Data Network
Standards
OpenLB
Open Library of Bioscience
Search
Advanced Search
Source: PubMed
The Medical letter on drugs and therapeutics
04 03, 2023;65 (1673): 56.
In Brief: Rezvoglar - another insulin glargine product interchangeable with Lantus.
No authors listed.
PMID: 37020341
DOI: 10.58347/tml.2023.1673c
Abstract
No abstract text available.
Keywords
Basaglar
Lantus
Rezvoglar
Semglee
efficacy
glargline
insulin
safety
MeSH Term
Humans
Insulin Glargine
Insulin
Hypoglycemic Agents
Diabetes Mellitus, Type 2
Blood Glucose
Chemicals
Insulin Glargine
Insulin
Hypoglycemic Agents
Blood Glucose
Journal Article
4
CITATIONS
4
Total citations
4
Recent citations
2.17
Field Citation Ratio
0.57
Relative Citation Ratio
Word Cloud
Created with Highcharts 10.0.0
Rezvoglar
insulin
Lantus
Brief:
-
another
glargine
product
interchangeable
Basaglar
Semglee
efficacy
glargline
safety
Similar Articles
Cited By
